References for Background:
1) Dr.Carmel Henzey (2015), 'Developmental Toxicology' lecture. [online] Accessed on: 22/2/15 Available at: Elearning.ucd.ie
References for Recreational Drugs:
1) Spohr, HL, Steinhausen, HC, 1996. Alcohol, pregnancy and the developing child. 1st ed. Cambridge: Cambridge University Press.
2) Centers for Disease Control and Prevention. 2013. Tobacco use and pregnancy. [ONLINE] Available at: http://www.cdc.gov/reproductivehealth/tobaccousepregnancy/. [Accessed 22 February 15].
3) Baby Centre. 2013. Illegal drugs in pregnancy. [ONLINE] Available at: http://www.babycentre.co.uk/a541318/illegal-drugs-in-pregnancy. [Accessed 22 February 15].
4) Ornes, Stephen. 2006. What Ever Happened to Crack Babies?. [ONLINE] Available at:http://discovermagazine.com/2006/dec/crack-baby-unfounded-stigma. [Accessed 23 February 15].
5) Mullally, A et al, 2011. Prevalence, predictors and perinatal outcomes of peri-conceptional alcohol exposure - retrospective cohort study in an urban obstetric population in Ireland. BMC Pregnancy and Child Birth, 11: 27.
References For Anticonvulsant: Phenytoin
1 Rang,Dale, 2012. Rang and Dale's pharmacology. 7th ed Elsevier Limited.Chapters: 44/57
2 lippincots modern pharmacology with clinical applications pg no:377 5th Edition
3 Easton JD (December 1972). "Potential hazards of hydantoin use". Ann. Intern. Med. 77 (6): 998–9
4 Beckmann CR et al. (2002). Obstetrics and Gynecology (4th ed.). Baltimore: Lippincott Williams & Wilkins.
5 Panayiotopoulos , CP, 2005. The Epilepsies: Seizures, Syndromes and Management
6 Ravindu Gunatilake, MD; Avinash S. Patil, MD,2013.Merck Manual
References for Vitamin A (By Emma Quinless):
1. Katzung, B.G. et al. (2009) Basic and Clinical Pharmacology. (11th Edition) pp 1027, 1055-1057 Mc Graw Hill, Lange.
Marletaz, F. et al. (2006) Retinoic Acid Signaling and the evolution of Chordates. [ONLINE] Available at: http://www.ijbs.com/v02p0038.htm [Accessed 28 February 2015]
2.Maija, H.Z. (1998) Vitamin A and Embryonic development. [ONLINE] Available at: http://jn.nutrition.org/content/128/2/455S.long. [Accesed 15 February 2015]
3.Huang, F.J. et al. (2006) Adverse Effects of Retinoic Acid on embryo development and the selective expression of retinoic acid receptors in mouse blastocytes. [ONLINE] Available at: http://humrep.oxfordjournals.org/content/21/1/202.full. [Access 23 February 2015]
4.Taizhou Hendfeng Pharmacrutical & Chemical Co., LTD. (2007) Tretinoin (Retinoic Acid). [ONLINE IMAGE] Available at: http://www.hfchem.cn/template/tretinoin.htm. [Accessed 22 February 2015]
5.Marshall, H. et al. (1996) Retinoids and the Hox genes. [ONLINE] Available at: http://www.ncbi.nlm.nh.gov/pubmed/8801179. [Accessed 22 February 2015]
6. Marletaz, F. et al. (2006) Retinoic Acid Signaling and the evolution of Chordates. [ONLINE] Available at: http://www.ijbs.com/v02p0038.htm [Accessed 28 February 2015]
7. Mitchell, C.A. (2010) Intracellular Signalling in Development, Cancer and Human Disease. [ONLINE IMAGE] Available at: http://www.med.monash.edu.au/biochem/research/projects/intracellular.html. [Accessed23 February 2015]
8. Rhinn, M. and Dolle, P. (2012) Retinoic Acid Signalling during Developmet. [ONLINE] Available at: http://dev.biologists.org/content/139/5/843.full . [Accessed 24 February 2015]
References For Thalidomide:
Adlard, Julian Weldon. "Thalidomide in the treatment of cancer." Anti-cancer drugs 11.10 (2000): 787-791
Barnhill, Raymond L., and A. Colin McDougall. "Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions." Journal of the American Academy of Dermatology 7.3 (1982): 317-323
Botting, Jack. "The history of thalidomide." Drug News Perspect 15.9 (2002): 604-611
Ghobrial, Irene M., and S. Vincent Rajkumar. "Management of thalidomide toxicity." The journal of supportive oncology 1.3 (2003): 194
Ito, Takumi, and Hiroshi Handa. "Deciphering the mystery of thalidomide teratogenicity." Congenital anomalies 52.1 (2012): 1-7
Ito, Takumi, et al. "Identification of a primary target of thalidomide teratogenicity." science 327.5971 (2010): 1345-1350
Stephens, Trent D., Carolyn JW Bunde, and Bradley J. Fillmore. "Mechanism of action in thalidomide teratogenesis." Biochemical pharmacology 59.12 (2000): 1489-1499
1) Dr.Carmel Henzey (2015), 'Developmental Toxicology' lecture. [online] Accessed on: 22/2/15 Available at: Elearning.ucd.ie
References for Recreational Drugs:
1) Spohr, HL, Steinhausen, HC, 1996. Alcohol, pregnancy and the developing child. 1st ed. Cambridge: Cambridge University Press.
2) Centers for Disease Control and Prevention. 2013. Tobacco use and pregnancy. [ONLINE] Available at: http://www.cdc.gov/reproductivehealth/tobaccousepregnancy/. [Accessed 22 February 15].
3) Baby Centre. 2013. Illegal drugs in pregnancy. [ONLINE] Available at: http://www.babycentre.co.uk/a541318/illegal-drugs-in-pregnancy. [Accessed 22 February 15].
4) Ornes, Stephen. 2006. What Ever Happened to Crack Babies?. [ONLINE] Available at:http://discovermagazine.com/2006/dec/crack-baby-unfounded-stigma. [Accessed 23 February 15].
5) Mullally, A et al, 2011. Prevalence, predictors and perinatal outcomes of peri-conceptional alcohol exposure - retrospective cohort study in an urban obstetric population in Ireland. BMC Pregnancy and Child Birth, 11: 27.
References For Anticonvulsant: Phenytoin
1 Rang,Dale, 2012. Rang and Dale's pharmacology. 7th ed Elsevier Limited.Chapters: 44/57
2 lippincots modern pharmacology with clinical applications pg no:377 5th Edition
3 Easton JD (December 1972). "Potential hazards of hydantoin use". Ann. Intern. Med. 77 (6): 998–9
4 Beckmann CR et al. (2002). Obstetrics and Gynecology (4th ed.). Baltimore: Lippincott Williams & Wilkins.
5 Panayiotopoulos , CP, 2005. The Epilepsies: Seizures, Syndromes and Management
6 Ravindu Gunatilake, MD; Avinash S. Patil, MD,2013.Merck Manual
References for Vitamin A (By Emma Quinless):
1. Katzung, B.G. et al. (2009) Basic and Clinical Pharmacology. (11th Edition) pp 1027, 1055-1057 Mc Graw Hill, Lange.
Marletaz, F. et al. (2006) Retinoic Acid Signaling and the evolution of Chordates. [ONLINE] Available at: http://www.ijbs.com/v02p0038.htm [Accessed 28 February 2015]
2.Maija, H.Z. (1998) Vitamin A and Embryonic development. [ONLINE] Available at: http://jn.nutrition.org/content/128/2/455S.long. [Accesed 15 February 2015]
3.Huang, F.J. et al. (2006) Adverse Effects of Retinoic Acid on embryo development and the selective expression of retinoic acid receptors in mouse blastocytes. [ONLINE] Available at: http://humrep.oxfordjournals.org/content/21/1/202.full. [Access 23 February 2015]
4.Taizhou Hendfeng Pharmacrutical & Chemical Co., LTD. (2007) Tretinoin (Retinoic Acid). [ONLINE IMAGE] Available at: http://www.hfchem.cn/template/tretinoin.htm. [Accessed 22 February 2015]
5.Marshall, H. et al. (1996) Retinoids and the Hox genes. [ONLINE] Available at: http://www.ncbi.nlm.nh.gov/pubmed/8801179. [Accessed 22 February 2015]
6. Marletaz, F. et al. (2006) Retinoic Acid Signaling and the evolution of Chordates. [ONLINE] Available at: http://www.ijbs.com/v02p0038.htm [Accessed 28 February 2015]
7. Mitchell, C.A. (2010) Intracellular Signalling in Development, Cancer and Human Disease. [ONLINE IMAGE] Available at: http://www.med.monash.edu.au/biochem/research/projects/intracellular.html. [Accessed23 February 2015]
8. Rhinn, M. and Dolle, P. (2012) Retinoic Acid Signalling during Developmet. [ONLINE] Available at: http://dev.biologists.org/content/139/5/843.full . [Accessed 24 February 2015]
References For Thalidomide:
Adlard, Julian Weldon. "Thalidomide in the treatment of cancer." Anti-cancer drugs 11.10 (2000): 787-791
Barnhill, Raymond L., and A. Colin McDougall. "Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions." Journal of the American Academy of Dermatology 7.3 (1982): 317-323
Botting, Jack. "The history of thalidomide." Drug News Perspect 15.9 (2002): 604-611
Ghobrial, Irene M., and S. Vincent Rajkumar. "Management of thalidomide toxicity." The journal of supportive oncology 1.3 (2003): 194
Ito, Takumi, and Hiroshi Handa. "Deciphering the mystery of thalidomide teratogenicity." Congenital anomalies 52.1 (2012): 1-7
Ito, Takumi, et al. "Identification of a primary target of thalidomide teratogenicity." science 327.5971 (2010): 1345-1350
Stephens, Trent D., Carolyn JW Bunde, and Bradley J. Fillmore. "Mechanism of action in thalidomide teratogenesis." Biochemical pharmacology 59.12 (2000): 1489-1499